Brief: IBio Received Regulatory Clearance To Initiate Its Phase 1 Clinical Trial Of Ibio-600 In Australia
08/04/2026 13:14
April 8 (Reuters) - iBio Inc IBIO.O: IBIO RECEIVED REGULATORY CLEARANCE TO INITIATE ITS PHASE 1 CLINICAL TRIAL OF IBIO-600 IN AUSTRALIA IBIO INC - PHASE 1 TRIAL OF IBIO-600 TO BEGIN DOSING IN Q2 2026 Source text: ID:nGNX6R37vB Further company coverage: IBIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on iBio
See all newsBrief: iBio - IBIO-610 Plus Semaglutide Preserves Lean Mass In Eight-Week Obese NHP Study
Brief: Ibio Reports Fiscal Year 2026 Financial Results And Provides Corporate Update
Brief: Ibio Reports Q3 Fiscal Year 2026 Financial Results And Provides Corporate Update
U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg
U.S. STOCKS ON THE MOVE-Hims & Hers, Chewy, Longeveron